Search Results 401-410 of 15988 for melatonin receptor agonists

  1. A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive Breast Cancer - Mayo Clinic

    The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

  2. Losartan and hydrochlorothiazide (oral route) - Mayo Clinic

    Losartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes the blood vessels to tighten. Losartan ...

  3. Chemotherapy For Clinical Trials - Mayo Clinic Research

    ... Receptor 2, also known as HER2-positive breast cancer. ... Receptor Positive, Metastatic ... Avelumab In Combination Regimens That Include An Immune Agonist ...

  4. Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE) - Mayo Clinic

    The purpose of the study is to evaluate the effectiveness, safety and patient-reported outcomes of peptide receptor radionuclide therapy (PRRT) with 177Lu ...

  5. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    T-cell receptor. - Individuals may not have received systemic anticancer treatment within the previous 6 months or radiation therapy within 2 weeks prior to ...

  6. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

    ... receptor positive/HER2-negative breast cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  7. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients - Mayo Clinic

    The purpose of this study is to combine robust clinical data (e.g., prior chemotherapy or radiation exposure, cumulative Peptide Receptor Radionuclide ...

  8. Overview - Insulin-Like Growth Factors Laboratory - Mayo Clinic Research

    Dr. Conover's research team is expanding knowledge about insulin-like growth factors (IGFs), the receptors that mediate their effects, the IGF binding proteins ...

  9. Publications - Mark A. Whealy, M.D. - Mayo Clinic

    ... agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans. Handb Clin Neurol. 2024; 199:17-42. View PubMed; Montenegro MM, Kissoon ...

  10. Mayo Clinic

    Mayo Clinic is a top-ranked hospital in the U.S., with campuses in Arizona, Florida, and Minnesota.